ICU blood test may predict deadly clots
NCT ID NCT06357403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will follow 1300 critically ill adults in intensive care to see if a blood test called anti-factor Xa activity can predict dangerous blood clots (deep vein thrombosis or pulmonary embolism). Researchers will also track bleeding risks, quality of life, and survival. The goal is to better understand how to prevent clots in very sick patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENOXAPARIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Medical University of Vienna
RECRUITINGVienna, 1090, Austria
-
Department of Internal Medicine, Medical University of Graz
RECRUITINGGraz, Styria, 8063, Austria
-
Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck
RECRUITINGInnsbruck, Tyrol, 6020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new device suck out deadly lung clots?
- A new exercise plan aims to get pulmonary embolism survivors back on their feet
- Can a sedative help rebuilt tissue survive after cancer surgery?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Your DNA could determine which heart drug works best
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers